Citius Oncology launches $15M equity and warrant offering; shares down

Citius Oncology (NASDAQ:CTOR) is offering up to $15M in common stock and accompanying warrants.

The offering includes up to $15M in pre-funded warrants and up to $15M in regular warrants, each convertible into common shares.

All warrants have a five-year term from the initial exercise date.

The company is also offering up to $750,000 in common stock underlying placement agent warrants.

CTOR shares fall 9.8% on Monday. 

Source: SEC filing